Babesia microti real-time polymerase chain reaction testing of Connecticut blood donors: Potential implications for screening algorithms

Transfusion

Volumn 53, Issue 11, 2013, Pages 2644-2649

  Johnson, Stephanie T ^a   Van Tassell, Eric R ^a   Tonnetti, Laura ^a   Cable, Ritchard G ^a   Berardi, Victor P ^a   Leiby, David A ^a  

^a AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ALGORITHM; ARTICLE; BABESIA MICROTI; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PARASITE TRANSMISSION; REAL TIME POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGY; SEROPREVALENCE; SPECIES ENDEMICITY; UNITED STATES;

ALGORITHMS; ANTIBODIES, PROTOZOAN; BABESIA MICROTI; BLOOD DONORS; CONNECTICUT; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOGLOBULIN G; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84887826763     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12125     Document Type: Article

References (21)

1. Vannier E, Krause PJ,. Human babesiosis. N Engl J Med 2012; 366: 2397-2407.
2. Leiby DA,. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev 2011; 24: 14-28.
3. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M,. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011; 155: 509-519.
4. Tonnetti L, Eder AF, Dy B, Kennedy J, Pisciotto P, Benjamin RJ, Leiby DA,. Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009; 49: 2557-2563.
5. Asad S, Sweeney J, Mermel LA,. Transfusion-transmitted babesiosis in Rhode Island. Transfusion 2009; 49: 2564-2573.
6. Johnson ST, Cable RG, Leiby DA,. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area. Transfusion 2012; 52: 1509-1516.
7. Leiby DA, Chung AP, Gill JE, Houghton RL, Persing DH, Badon S, Cable RG,. Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti. Transfusion 2005; 45: 1804-1810.
8. Johnson ST, Cable RG, Tonnetti L, Spencer B, Rios J, Leiby DA,. Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007. Transfusion 2009; 49: 2574-2582.
9. Krause PJ, Telford SR 3rd, Ryan R, Conrad PA, Wilson M, Thomford JW, Spielman A,. Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis 1994; 169: 923-926.
10. Vermont Department of Health. Babesiosis. 2012. [cited 2012 May 15]. Available from: URL: http://healthvermont.gov/prevent/zoonotic/tickborne/ Babesiosis.aspx
11. Young C, Chawla A, Berardi V, Padbury J, Skowron G, Krause PJ,. Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program. Transfusion 2012; 52: 1523-1529.
12. Spielman A, Wilson ML, Levine JF, Piesman J,. Ecology of Ixodes dammini-borne human babesiosis and Lyme disease. Annu Rev Entomol 1985; 30: 439-460.
13. Swanson SJ, Neitzel D, Reed KD, Belongia EA,. Coinfections acquired from ixodes ticks. Clin Microbiol Rev 2006; 19: 708-727.
14. American Association of Blood Banks. Standards for blood banks and transfusion services. 27th ed. Bethesda (MD): American Association of Blood Banks; 2011.
15. Devine PBV, Molloy P, Brissette E, Hewins M, Young C,. Babesia microti tests for blood donor screening. Transfusion 2011; 51: 204A.
16. Dodd RY, Notari EP 4th, Stramer SL,. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-979.
17. Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, Fang CT, Dodd RY,. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009; 49: 1609-1620.
18. Ling AE, Robbins KE, Brown TM, Dunmire V, Thoe SY, Wong SY, Leo YS, Teo D, Gallarda J, Phelps B, Chamberland ME, Busch MP, Folks TM, Kalish ML,. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA 2000; 284: 210-214.
19. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, Matud JL, Prince HE, Lanciotti RS, Wright DJ, Linnen JM, Caglioti S,. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008; 198: 984-993.
20. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP,. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351: 760-768.
21. Seed CR, Cheng A, Ismay SL, Bolton WV, Kiely P, Cobain TJ, Keller AJ,. Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT. Transfusion 2002; 42: 1365-1372.